Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
62,337,402
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
29,539,370
-
Shares change
-
-4,314,732
-
Total reported value, excl. options
-
$10,842,560
-
Value change
-
-$793,553
-
Put/Call ratio
-
0%
-
Number of buys
-
35
-
Number of sells
-
54
-
Price
-
$0.3671
Institutional Holders of Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV) as of Q2 2025
As of 30 Jun 2025 Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,539,370 shares of stock of the company.
Largest 10 holders included Frazier Life Sciences Management, L.P., BML Capital Management, LLC, Aisling Capital Management LP, VANGUARD GROUP INC, Opaleye Management Inc., DELTEC ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Rangeley Capital, LLC, and ExodusPoint Capital Management, LP.
This table shows 98 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.